Zobrazeno 1 - 10
of 33
pro vyhledávání: '"F H Glorieux"'
Autor:
R M, Patel, S C S, Nagamani, D, Cuthbertson, P M, Campeau, J P, Krischer, J R, Shapiro, R D, Steiner, P A, Smith, M B, Bober, P H, Byers, M, Pepin, M, Durigova, F H, Glorieux, F, Rauch, B H, Lee, T, Hart, V R, Sutton
Publikováno v:
Clinical genetics. 87(2)
Osteogenesis imperfecta (OI) is the most common skeletal dysplasia that predisposes to recurrent fractures and bone deformities. In spite of significant advances in understanding the genetic basis of OI, there have been no large-scale natural history
Publikováno v:
Monatsschrift Kinderheilkunde. 148:334-341
Autor:
Florence Comite, Alice F. Ellison, Cynthia Smith, A R Poole, R Travers, Caren M. Gundberg, Dana S. Schwartz, Marc S. Keller, Karl L. Insogna, F H Glorieux, Maryann Mitnick, Ronald L. Horst, Thomas O. Carpenter, D Carey
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 81:2381-2388
Therapy for X-linked hypophosphatemia (XLH) only partially corrects skeletal lesions and is often complicated by hyperparathyroidism. 24,25(OH)2 D3 improves skeletal lesions in a murine model of XLH and suppresses PTH secretion in animals. Therefore,
Autor:
F. H. Glorieux
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 80:2255-2258
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 75:879-885
Current treatment of X-linked hypophosphatemia (XLH) employs the combined administration of oral phosphate and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]. Although this drug regimen significantly improves the clinical course of the disease in children,
Autor:
F H, Glorieux
Publikováno v:
Journal of pediatric endocrinologymetabolism : JPEM. 14
Children with osteogenesis imperfecta (OI) suffer recurrent fractures resulting in pain, deformity and disability. There is no accepted medical therapy for the condition other than symptomatic pain relief, and surgical correction of the deformities.
Autor:
D, Primorac, D W, Rowe, M, Mottes, I, Barisić, D, Anticević, S, Mirandola, M, Gomez Lira, I, Kalajzić, V, Kusec, F H, Glorieux
Publikováno v:
Croatian medical journal. 42(4)
Osteogenesis imperfecta (OI), or brittle bone disease, is a heritable disorder characterized by increased bone fragility. Four different types of the disease are commonly distinguished, ranging from a mild condition (type I) to a lethal one (type II)
Autor:
F H, Glorieux
Publikováno v:
Journal of pediatric endocrinologymetabolism : JPEM. 13
Osteogenesis imperfecta (OI) is a heterogeneous group of disorders principally affecting type I collagen. Children with the severe forms of the condition suffer recurrent fractures resulting in limb and spine deformities, and restricted ambulation. R
Publikováno v:
Acta paediatrica (Oslo, Norway : 1992). 89(7)
Autor:
F H, Glorieux, R, St-Arnaud
Publikováno v:
Recent progress in hormone research. 53
Pseudovitamin D-deficiency rickets (PDDR) is the first identified inborn error of vitamin D metabolism. Its clinical course is similar to that of nutritional rickets due to simple vitamin D deficiency. The treatment of choice is replacement therapy w